1 asset in Perihilar Intrahepatic Cholangiocarcinoma
Therapeutic assets addressing Perihilar Intrahepatic Cholangiocarcinoma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Fluorouracilum Perihilar Intrahepatic Cholangiocarcinoma | Peking University | P2 | CCC (53) |